EAST HANOVER, N.J., July 5, 2011 /PRNewswire/ -- Unity Management Group, Inc. (OTC: UYMG) "UNITY" (or the "Company") (MCC) Metropolitan Computing Corporation has received authorization for a second purchase order to come in this week from Bristol Meyers Squibb, BMS Pharmaceuticals LTD., one of the largest pharmaceutical companies ,for $108,000.00 . MCC completed installation on the first order from Bristol Meyers Squibb UK, with successful results, using their complete instrumentation and calibration services to upgrade preexisting equipment with MCC's proprietary Advanced Instrumentation Monitor technology (AIM).
The MCC instrumentation monitoring system is engineered to integrate hardware and software into a complete data acquisition and analysis system. AIM is a state-of-the-art tool that facilitates research, process development, scale-up, and production of tablets and capsules. It is Windows NT based and provides continuous batch recordings and process optimization for all instrumented equipment. The system is modular and is contained in a mobile enclosure or laptop computer that can be moved between different types of instrumented equipment. Each system can be custom tailored to match customer specific needs.
"We continue to improve, and expand our company with this second order from BMS LTD," said Ron Berman President. "We are continuing to expand our range of development and becoming the leader in our industry. With the consolidation and streamlining of the entire major pharmaceutical companies today our abilities to upgrade existing equipment, to save time and expense has become very valuable."
About Bristol Meyers Squibb:
At Bristol-Myers Squibb, our BioPharma strategy uniquely combines the reach and resources of a major pharma company with the entrepreneurial spirit and agility of a successful biotech company. With this strategy, we focus on our customers' needs, giving maximum priority to accelerating pi
|SOURCE Unity Management Group, Inc.|
Copyright©2010 PR Newswire.
All rights reserved